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Summary
The potential aerosolised transmission of severe acute respiratory syndrome coronavirus-2 is of global
concern. Airborne precaution personal protective equipment and preventative measures are universally
mandated for medical procedures deemed to be aerosol generating. The implementation of these measures is
having a huge impact on healthcare provision. There is currently a lack of quantitative evidence on the number
and size of airborne particles produced during aerosol-generating procedures to inform risk assessments. To
address this evidence gap, we conducted real-time, high-resolution environmental monitoring in ultraclean
ventilation operating theatres during tracheal intubation and extubation sequences. Continuous sampling with
an optical particle sizer allowed characterisation of aerosol generation within the zone between the patient and
anaesthetist. Aerosol monitoring showed a very low background particle count (0.4 particles.l1) allowing
resolution of transient increases in airborne particles associated with airway management. As a positive
reference control, we quantitated the aerosol produced in the same setting by a volitional cough (average
concentration, 732 (418) particles.l1, n = 38). Tracheal intubation including facemask ventilation produced
very low quantities of aerosolised particles (average concentration, 1.4 (1.4) particles.l1, n = 14, p < 0.0001
vs. cough). Tracheal extubation, particularly when the patient coughed, produced a detectable aerosol (21
(18) l1, n = 10) which was 15-fold greater than intubation (p = 0.0004) but 35-fold less than a volitional cough
(p < 0.0001). The study does not support the designation of elective tracheal intubation as an aerosol-
generating procedure. Extubation generates more detectable aerosol than intubation but falls below the
current criterion for designation as a high-risk aerosol-generating procedure. These novel findings from real-
time aerosol detection in a routine healthcare setting provide a quantitative methodology for risk assessment
that can be extended to other airway management techniques and clinical settings. They also indicate the need
for reappraisal of what constitutes an aerosol-generating procedure and the associated precautions for routine
anaesthetic airwaymanagement.
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Introduction
The severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) and associated coronavirus disease 2019
(COVID-19) pandemic have had an unprecedented impact
on global health and the world economy. Drastic
interventions to limit transmission have been introduced
worldwide, such as lockdowns, physical distancing and the
use of personal protective equipment (PPE). Respiratory
secretions have a high SARS-CoV-2 viral load and are
believed to be the main source for person-to-person
transmission [1, Cevik et al., preprint: doi.org/10.1101/
2020.07.25.20162107]. Coughing and sneezing atomise
respiratory secretions into particles with different
aerodynamic properties according to size; particles greater
than 20 µm in diameter are conventionally defined as
droplets and tend to follow a ballistic trajectory. These
droplets can either directly contact and infect a susceptible
individual within close proximity or may settle on nearby
surfaces (fomites) where viable virus can exist for up to 72 h
[2, 3]. This direct droplet and indirect contact transmission
are considered the predominant modes of spread of SARS-
CoV-2, providing the rationale for physical distancing and
hand hygiene as primary measures to reduce the incidence
of COVID-19.
The extent to which SARS-CoV-2 is transmitted by the
airborne route is a controversial topic [3–6]. Aerosolised
particles (typically considered to be < 20 µm in diameter
and particularly those of < 5 µm) may transmit infection by
deposition on respiratory epithelium and can potentially
transit the full extent of the respiratory tract. It is also feared
that these small particles may remain airborne for long
periods and may be carried far from the site of origin by air
currents. The risks from aerosols and optimum methods of
preventing transmission are under active debate [7–10]. To
minimise airborne transmission of SARS-CoV-2 to
healthcare workers, specific patient care activities have
been designated as aerosol-generating procedures.
Tracheal intubation and extubation, manual ventilation via
facemask and respiratory tract suctioning are all designated
as aerosol-generating procedures [11–13]. Many
organisations, including theWorld Health Organization and
the public health bodies of the UK, have recommended that
those undertaking these aerosol-generating procedures
wear airborne precaution PPE consisting of a fitted face-
piece (FFP3 or NR95), a long sleeved, fluid-resistant gown,
gloves and eye protection [1, 13].
The quantitative evidence base for these guidelines is
weak and the relative magnitude of risk for each aerosol-
generating procedure is unknown [3, 11]. The evidence for
this designation is largely based on retrospective cohort
and case-controlled studies of transmission during the
severe acute respiratory syndrome (SARS) pandemic in
2003 [12, 14]. A systematic review of these studies
concluded that tracheal intubation was associated with a
significant increase in risk of disease transmission but
categorised the quality of available evidence as “very low
quality based on GRADE” and identified that “a significant
research gap exists in the epidemiology of the risk of
transmission of acute respiratory infections from patients
undergoing aerosol generating procedures to healthcare
workers, and clinical studies should be carefully planned to
address specific questions around the risks of transmission
in these settings” [12]. An attempt to provide such evidence
employed aerosol sampling traps placed in the vicinity of
patients with H1N1 influenza during periods of hospital
care, including some with aerosol-generating procedures,
but this large study did not clearly demonstrate an
increased risk above background of detecting virus RNA in
the air [15]. There is still no quantitative evidence of
increased aerosol generation from the designated aerosol-
generating procedures, which likely relates to the challenge
of obtaining such measurements in routine healthcare
settings.
When considering the risk of transmission of SARS-
CoV-2, it is helpful to reflect on the definition of an aerosol-
generating procedure that has been expressly stated as
“aerosol generating procedures are considered to have a
greater likelihood of producing aerosols compared to
coughing.” [16]. There is a comparatively large quantitative
evidence base around aerosolised particle generation by
coughing from laboratory-based investigations with sizes
ranging from visible droplets to submicron particles [17–
20]. Given the uncertain balance of potential risks and
benefits associated with the protective strategies put in
place to limit viral transmission, it is important to
quantitatively assess the degree to which individual aerosol-
generating procedures generate aerosolised particles. In
this study, we have quantitated airborne particle emission in
real-time during tracheal intubation and extubation, using
particle analysis instruments in a working operating theatre
environment and compared this with volitional coughs as a
reference.
Methods
A prospective environmental monitoring study was
conducted to quantitate the airborne particle size
distribution andparticle number concentration producedby
aerosol-generating procedures in four operating theatres in
a UK hospital (North Bristol NHS Trust). Institutional Review
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Board approval for the study was given by the Faculty of Life
Science and Science Research Ethics Committee at the
University of Bristol. As this was an observational study, the
anaesthetic and theatre team undertook their normal
practice during airway management. The researchers were
not involved in thedelivery of anaesthetic care.
Observations were made within operating theatres
with an ultraclean, laminar flow ventilation system
(EXFLOW 32; Howorth Air Technology, Farnworth, UK)
with high efficiency particulate air (HEPA) filtration. This
ventilation system has a canopy ‘clean zone’ where
surgical procedures are performed; the air circulation
velocity is 0.2 m.s1 at 1 m above the floor below the
canopy and produces 500–650 air changes per hour. All
aerosol recordings were performed under the canopy.
Air temperature in theatres was set to 20 °C and humidity
between 40 and 60%.
A lightweight, portable Optical Particle Sizer (TSI
Incorporated, model 3330, Shoreview, NM, USA) was used
which samples air at 1 l.min1 and detects particles by laser
optical scattering. The optical particle sizer reports the
particle number concentration and size distribution within
the diameter range 300 nm to 10 µmwith a time resolution
of 1 s. It is widely used for aerosol studies both within
laboratories and clean rooms to use in more demanding
applications in the outside environment. It is calibrated by
the manufacturer using polystyrene latex spheres and its
performance conforms to the ISO standard 21501-4:2018.
A sampling funnel was 3D printed (RAISE3D Pro2 Printer,
3DGBIRE, Chorley, UK) with a maximum diameter of
150 mm, cone height of 90 mm with a 10-mm exit port. A
conductive silicone sampling tube of 2 m length and
internal diameter 4.8 mm (3001788, TSI) connected the
sampling funnel to the optical particle sizer. This had an
internal volume of 145 ml giving a transit lag between the
funnel and the particle sizer (with a flow of 1 l.min1) of 8.7 s
which was taken into account in the time registration of
measurements.
In an initial set of pilot studies in the ultraclean theatre
environment, it was possible to reliably detect a volitional
cough from a subject lying supine (JB) at a sampling
distance of 0.5 m from the mouth to the funnel. Sampling at
0.5 m approximates the distance from the face of the airway
management practitioner to the patient’s mouth during the
intubation sequence. For recordings during intubation and
extubation, the sampling funnel was, therefore, positioned
at a distance of 0.5 m facing the patient’s mouth and close
to the anaesthetist (Fig. 1). For several extubations, we
repositioned the funnel to lie above and behind the
patient’s head, again at 0.5 m and facing the patient’s
airway. The funnel was handheld to ensure it could be
quickly removed from the airway management zone in
case of clinical need (this was not needed in the course of
the study). All healthcare workers, and members of the
investigating team, wore airborne precaution PPE during
aerosol-generating proceduremeasurements.
Tracheal intubation and extubation consist of a series of
discrete events and procedures which we designated as
sequences. For tracheal intubation measurements,
anaesthetic induction followed a conventional sequence
with pre-oxygenation, intravenous induction by
administration of anaesthetic and neuromuscular blocking
drugs, manual ventilation of the lungs via a facemask, direct
laryngoscopy and intubation of the trachea followed by
inflation of the tracheal tube cuff which was the reference
end point of the intubation sequence. Standard anaesthetic
monitoring was used including waveform capnography.
This whole intubation sequence typically lasted 3–4 min
with continuous aerosol monitoring throughout. The 5-min
period before inflation of the tracheal tube cuff was
analysed.
For recordings during tracheal extubation, the level of
anaesthesia was lightened, spontaneous breathing allowed
Figure 1 Simulation of aerosolmeasurement approach
within operating theatre environment. The sampling funnel
was positioned 0.5 m above the source of aerosol in the
airwaymanagement zone allowing a sampling streamof air
(1 l.min1) to be routed to the optical particle sizer.
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to recommence, the oropharynx was suctioned before the
tracheal tube cuff was deflated, and the trachea was then
extubated according to the anaesthetist’s normal practice.
After extubation and confirmation of airway patency, the
patient received oxygen via an anaesthetic facemask and
then a HudsonTM mask. The reference point for the start of
extubation was tracheal tube cuff deflation (releasing the
seal on the airway). Continuous monitoring with the optical
particle sizer was conducted throughout and a period of
3 min before and up to 2 min after cuff deflation was
analysed.
Airway management events including cuff inflation,
deflation and coughs were recorded contemporaneously
by the researcher using a time stamp application (Emerald
Timestamp, Emerald Sequoia LLC, https://emera
ldsequoia.com/ts/index.html). Data were exported from the
TSI optical particle sizer, processed in the TSI Aerosol
Instrument Manager software, and analysed in Origin Pro
(Originlab, Northampton, MA, USA) and Prism v8
(Graphpad, San Diego, CA, USA). Comparisons were made
between aerosol-generating events with unpaired t-tests
with the significance level set at p < 0.05.
Results
Environmental aerosol monitoring was conducted over a
3-week period during operating lists for orthopaedic
trauma and neurosurgical emergencies. Recordings
were made of 19 intubations and 14 extubations. The
conduct of anaesthesia was left at the discretion of the
anaesthetist, who ranged in experience from junior
trainee to senior consultant. Control environmental
monitoring recordings showed the ultraclean, laminar
flow ventilation and air filtration system produced a very
low background of aerosol particles averaging 0.4 l1
when the theatre was empty, and 3.4 l1 when the theatre
was in use but no aerosol-generating procedures were in
progress. Thirty-eight volitional coughs were sampled at
0.5-m distance. These coughs showed a characteristic
profile with a rapid and transient spike of expectorated
particles (Fig. 2a). Peak aerosol concentration occurred
2 s after the cough was registered and averaged 1310
(905) particles.l1. The spike in aerosol particle count
decayed back to baseline with a time constant of
approximately 2.7 s. Each cough contained an average of
134 (77) detected airborne particles (over the 12 s
window). The large majority of the particles were < 1 µm
diameter (Fig. 2d). Although we conducted our
monitoring under the ultraclean ventilation canopy, the
temporary suspension of the laminar flow system
(0.2 m.s1) did not alter the number of particles detected
per cough: 164 (80) with ventilation on vs. 153 (82) with
ventilation off (p = 0.77, n = 9 per group).
All tracheal intubation sequences included manual
facemask ventilation and three also required repeated
attempts at laryngoscopy/intubation. The mean (SD) number
of particles detected in a 5-min period during anaesthetic
induction and intubation was 7 (6) (n = 14), compared with a
background in the empty theatre of approximately two
particlesper 5-minperiod (Fig. 2b). The average concentration
of particles recorded during the intubation period (1.4
(1.4) l1, n = 14) was 500-fold lower than the mean (SD)
concentration recorded during volitional coughs (732 (418)
particles.l1, n = 38, p < 0.0001). Similarly, the maximum
concentration recorded during intubation averaged across
events (77 (49) particles.l1, n = 14) was 22-fold lower than
that seen with volitional coughs (1688 (872), n = 38,
p < 0.0001). An equivalent series of aerosol measurements
during tracheal intubation with laminar flow ventilation
suspendedproduceda similar particle count to that seen in the
presenceof flow (6 (2) particleswith flowoff, n = 5, p = 0.65 vs.
flowon).
Extubation produced a mean (SD) concentration of
aerosolised particles of 21 (18) l1 (n = 10, Fig. 2c) which
was 35-fold lower than that seen during a volitional cough
(p < 0.0001) but 15-fold greater than that seen during
intubation (p = 0.0004). The maximum concentration
recorded during extubation averaged across events (432
(209) particles.l1, n = 10) was lower than that seen with
volitional coughs (1688 (872), n = 38, p < 0.0001). The
average total number of particles detected during the
period of extubation was 100 (85). This is similar to that
detected during a single volitional cough, although
sampling during extubation summed particles produced
over 5 min and each cough over 12 s. During four of the ten
extubations, the patient coughed at least once (typically
after tube removal) (Fig. 2c). These extubation coughs
produced aerosolised particles of a similar size distribution
to the reference coughs (Fig. 2d) but were always smaller in
magnitude than the average volitional cough and, on
average, produced only a quarter of the number of
particles: 33 (10) (from a total of five coughs during four
extubations, Fig. 2e). Because the usual position for the
anaesthetist during extubation is to stand above andbehind
the patient, who is typically semi-recumbent, a further set of
aerosol recordings were made with the particle collector
located in that position (0.5 m away and still facing towards
the patient). Aerosol monitoring from that position during
extubation (three with cough events) greatly decreased the
concentration of detected airborne particles to close to
background levels seen in an active theatre (3.7 (5.9) l1).
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Figure 2 Aerosolmeasurements during intubation and extubation in operating theatre environment. (a) Temporal profile of
aerosol generation from volitional coughs. Individual recordings (n = 38) represented on heatmap showing the total number
particle concentration over time. Average time course plotted (meanwith 95%CI) showing a peak after 2 s and a rapid decay
back to baseline. (b) Profile of the total number concentration of aerosol detected during the critical phase of intubation (arrow
at 300 smarks completion of intubationwith cuff up).When plotted on the same scale as the cough (b) then this looks essentially
flat andwhen shownon a ten-fold expanded scale below it can be seen that it is not significantly different to baseline as the
confidence intervals always span zero (mean  95%CI). (c) Extubation recordings fromeach patient (n = 10) plotted as the
average and individually as rows on heatmap of number concentration of particles (lower, on same scale as b). This showed
sporadic aerosol events (red, ringed) after cuff deflation set on a lowbaseline level of particles. The average concentration of
aerosol shown abovewas lowoverall (mean  95%CI). (d) The extubation cough events (n = 5) had a similar aerosol particle
size distribution to volitional coughswith a predominance of diameters < 1 µm (mean  SD). (e) The extubation coughswere of
a smallermagnitude than the volitional coughs (particle number concentration profile shown overlaid,mean  95%CI).
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Discussion
We conducted aerosol sampling in an ultraclean operating
theatre environment during routine clinical practice
enabling quantitative measurement of aerosols produced
by tracheal intubation and extubation. Using the quantity
and concentration of aerosolised particles generated by
volitional coughs as a reference, we have shown that both
intubation and extubation sequences produce less aerosol
than voluntary coughing. For the sequence of tracheal
intubation, in particular, the concentration of aerosol
generated is several orders of magnitude less than a single
cough and is only very modestly above background levels
of circulating particles in an ultraclean theatre. These
findings demonstrate that the process of tracheal intubation
is associatedwith a very low risk of aerosol generation.
Standard anaesthetic induction and intubation
sequences are designed to obtund airway reflexes and the
use of a neuromuscular blocking drug ensures that the
anaesthetised patient can neither breathe nor cough. Of
note, we detected no increases in aerosolised particles
above the patient’s face during anaesthesia, facemask
ventilation, airway suction and, on occasion, several
repeated attempts at intubation. This reflects typical clinical
practice by anaesthetists with a range of experience,
providing further reassurance regarding the low level of
aerosol generation.
A more nuanced picture is seen during the tracheal
extubation sequence where aerosol concentration was
greater than that seen with intubation but substantially less
than a single cough. The total number of expectorated
airborne particles (over a 5-min period) was similar to a
single volitional cough. Indeed, a cough event was noted
clinically in 50% of extubations and this was frequently
detected as an aerosol spike. These extubation coughs
produced a similar particle size distribution but there were
fewer airborne particles than with volitional coughs
(approximately 25%). Extubation cough aerosol was also
transient and only detectable for approximately 5 s.
Therefore, it would appear that aerosol generation during
extubation with a cough is quantitatively different from
extubationwithout a cough. Although a cough at extubation
may be interpreted as a positive sign signalling the return of
protective airway reflexes, it is likely to increase the risk of
aerosolised particle generation. Therefore, mitigation
strategies should be considered to reduce the risk of
coughing and exposure to aerosols. As sampling showed
much reduced particle numbers behind the patient’s head
compared with above their airway, clinician exposure could
be reduced by the simple expedient of standing behind the
patient’s head (as is conventional) and, thus, out of the direct
stream of any potential cough plume. Coughing on
extubation could also be minimised by modifying the
anaesthetic technique in higher risk patients [21].
The combination of monitoring within an ultraclean
ventilation theatre and the use of a highly sensitive optical
particle sampler has afforded sufficient resolution to
quantitate aerosol generation in real time during
anaesthetic delivery. To put this in context, it is worth noting
that we are unaware of any previous recording of aerosol
generated even by coughing in a routine healthcare
environment as this normally requires highly specialised
and controlled laboratory conditions [17–20]. The
ultraclean laminar flow ventilation system theatre had a very
low level of airborne particles (0.4 l1); in comparison the
baseline aerosolised particle concentration in a nearby non-
laminar theatre wasmore than 3 orders ofmagnitude higher
(15 9 103 l1), which would have precluded detection of
aerosols generated either by tracheal intubation or
extubation (and perhaps even a cough). To assess the
impact of the laminar flow on our observations, we
undertook measurements with the ultraclean theatre
ventilation on and off both for coughing and for tracheal
intubation and these did not differ. This demonstrates that
the low aerosol particle counts were not secondary to
immediate aerosol clearance by high laminar ventilation
flows. Although we did not assess the impact of ventilation
flow on the aerosol generated during extubation (because
of the pragmatic issue of turning off the ventilation while the
case is in theatre and the perceived need to disperse any
accumulated aerosol) we have no reason to believe, based
on the cough and intubation measurements, that the
presence of laminar flow has materially influenced these
extubationmeasurements.
There are a number of limitations to the study and these
include a relatively small number of observations, the use of
pragmatic design without control over the specific
anaesthetic administered or the grade of practitioner and
sampling aerosol from a limited arc encompassed by the
funnel. The reference coughs were from a single subject
(one of the investigators), but data from another study
(Brown et al., unpublished data) indicate that they were not
outliers when compared with other healthy subjects.
Additionally, we have made no measurements from subjects
known to have COVID-19 or other intercurrent respiratory
comorbidity, which would be an important area for
investigation, although challenging to conduct. The
measurements were taken during anaesthesia for patients
receiving urgent orthopaedic and neurosurgical interventions
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and may not be generalisable to intubations in a critical care/
emergency setting thatmaybeconducted in extremis.
Importantly, it should be acknowledged that we are
unable to make any conclusion about the risk of actual
SARS-CoV-2 transmission as aerosol generation is still only a
presumed risk-factor and particle number concentration is a
plausible but unproven surrogate measure of that infection
risk. We have presented our data as mean particle
concentration during the event, maximum concentration
recorded during the epoch and total numbers of detected
airborne particles and note that there is no available
evidence to indicate which measure will prove to be the
best surrogate measure of infection risk [3]. Other
dimensions that are likely to be important are the size
distribution of the aerosolised particles (which influences
their airborne transport and ability to be carried into the
respiratory tract), the total volume of expectorate (which can
be derived if assumptions about sphericity and composition
are made) and the concentration of live virions within the
particles (not measured here). Eachmeasure has limitations,
but we consider that the average concentration over time
gives the best estimate of the relative exposure smoothed
over the at-risk period during which particles may be
inhaled or deposited on mucous membranes. We note that
the peak concentration is likely to overestimate the risk; for
example, a single particle detected in a 1-s time bin during
an intubation sequence (5-min period of recording) would
correspond to a maximum of 60 particles.l1 (with 1 l.min1
air flow through the particle detector). However, this is
probably better represented as the average concentration
of 0.2 particles.l1 when assessing the relative risk over time,
reflecting the fact that no particles are detected for 299 of
the 300 s recording period. Notwithstanding these
considerations, we believe that our aerosol measurements
constitute a valuable quantitative dataset and we note that
the methodology could be applied to other anaesthetic
airway management techniques and designated aerosol-
generating procedures to extend the relative risk ranking.
Our results for the risk of aerosol generation associated
with tracheal intubation are at odds with previous
retrospective evidence that was used to designate
intubation in an aerosol-generating procedure [12, 14].
These studies found an association between acquiring
SARS and being in the room during intubation but without
any measure of aerosol generation. It is difficult to directly
compare these two sources of evidence: in our study, all
patients received a controlled anaesthetic induction that
included a neuromuscular blocking drug. Conversely,
during the SARS epidemic patients were unwell, may have
been coughing during the intubation sequence and it is
likely that viral secretion was at peak levels at the point of
initiating intensive care management (which is not the case
for COVID-19 Cevik et al., preprint: doi.org/10.1101/2020.
07.25.20162107). It is equally plausible that other
mechanisms of transmission, such as direct exposure to
respiratory secretions or fomites or association between
those who undertook tracheal intubation and performance
of other high-risk activities, could have contributed to the
spread of SARS.
By the definition noted earlier, aerosol-generating
procedures are considered to have a greater likelihood of
producing aerosols compared with coughing [16]. Our
study indicates that the process of elective tracheal
intubation produces a barely recordable increase in aerosol
and, consequently, should not be designated as an aerosol-
generating procedure. When a patient coughs during
tracheal extubation, a measurable particle plume is
produced but the aerosol is still smaller than a single
volitional cough. These relative risks aee4 of aerosol
generation need to be balanced against the knowledge that
the use of airborne precaution PPE has substantial impact
on clinical practice. Additionally, methods introduced to
mitigate the risks posed by bio-aerosols have reduced
operating theatre turnover, decreased hospital productivity
and increased waiting times for elective and cancer surgery.
A further important consideration relates to the cost and
limited supply of PPE which has to be targeted to
appropriate healthcare settings on the basis of risk. These
results, therefore, should help inform future airborne
prevention PPE guidelines by providing evidence on the
relative risk of aerosol generation associated with tracheal
intubation and extubation.
Acknowledgements
This study was supported by the Elizabeth Blackwell
Institute with funding from the University of Bristol’s alumni
and friends. BRB is supported by the Natural Environment
Research Council (NE/P018459/1). No other external
funding or competing interests declared.
References
1. Cook TM. Personal protective equipment during the
coronavirus disease (COVID) 2019 pandemic – a narrative
review.Anaesthesia 2020;75: 920–7.
2. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and
surface stability of SARS-CoV-2 as compared with SARS-CoV-1.
NewEngland Journal ofMedicine 2020;382: 1564–7.
3. Wilson NM, Norton A, Young FP, Collins DW. Airborne
transmission of severe acute respiratory syndrome coronavirus-
2 to healthcare workers: a narrative review. Anaesthesia 2020;
75: 1086–95.
4. Miller SL, Nazaroff WW, Jimenez JL, et al. Transmission of SARS-
CoV-2 by inhalation of respiratory aerosol in the Skagit Valley
180 © 2020 TheAuthors.Anaesthesia published by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists
Anaesthesia 2021, 76, 174–181 Brown et al. | Aerosol generation during intubation and extubation
Chorale superspreading event. Indoor Air 2020. Epub 26
September. doi.org/10.1111/ina.12751
5. Morawska L, Milton DK. It is time to address airborne
transmission of COVID-19. Clinical Infectious Diseases 2020.
Epub 7 July. https://doi.org/10.1093/cid/ciaa939.
6. Schutzer-Weissmann J, Magee DJ, Farquhar-Smith P. Severe
acute respiratory syndrome coronavirus 2 infection risk during
elective peri-operative care: a narrative review. Anaesthesia
2020. Epub 11 July. https://doi.org/10.1111/anae.15221.
7. Asadi S, Bouvier N, Wexler AS, Ristenpart WD. The coronavirus
pandemic and aerosols: does COVID-19 transmit via expiratory
particles? Aerosol Science and Technology 2020. Epub 3 April.
https://doi.org/10.1080/02786826.2020.1749229
8. Jayaweera M, Perera H, Gunawardana B, Manatunge J.
Transmission of COVID-19 virus by droplets and aerosols: a
critical review on the unresolved dichotomy. Environmental
Research 2020. Epub 13 June. https://doi.org/10.1016/j.envre
s.2020.109819.
9. Liu Y, Ning Z, Chen Y, et al. Aerodynamic analysis of SARS-CoV-
2 in twoWuhan hospitals.Nature 2020;582: 557–60.
10. Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying
airborne transmission as the dominant route for the spread of
COVID-19. Proceedings of the National Academy of Sciences of
theUnited States of America 2020;117: 14857–63.
11. NHS National Services Scotland and Health Protection




12. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol
generating procedures and risk of transmission of acute
respiratory infections to healthcare workers: a systematic
review. PLoSOne 2012;7: e35797.
13. Public Health England. COVID-19: personal protective




14. Davies A, Thomson G, Walker J, Bennett A. A review of the risks
and disease transmission associated with aerosol generating
medical procedures. Journal of Infection Prevention 2009; 10:
122–6.
15. Thompson KA, Pappachan JV, Bennett AM, et al. Influenza
aerosols in UK hospitals during the H1N1 (2009) pandemic –
the risk of aerosol generation duringmedical procedures. PLoS
One 2013;8: e56278.
16. Public Health England. Infection control precautions to
minimise transmission of acute respiratory tract infections in
healthcare settings. 2016. https://www.gov.uk/government/pub
lications/respiratory-tract-infections-infection-control (accessed
08/09/2020).
17. Stelzer-Braid S, Oliver BG, Blazey AJ, et al. Exhalation of
respiratory viruses by breathing, coughing, and talking. Journal
ofMedical Virolology 2009;81: 1674–9.
18. Yang S, Lee GW, Chen CM, Wu CC, Yu KP. The size and
concentration of droplets generated by coughing in human
subjects. Journal of AerosolMedicine 2007;20: 484–94.
19. Johnson GR, Morawska L, Ristovski ZD, et al. Modality of human
expired aerosol size distributions. Journal of Aerosol Science
2011;42: 839–51.
20. Zayas G, Chiang MC, Wong E, et al. Cough aerosol in healthy
participants: fundamental knowledge to optimize droplet-
spread infectious respiratory disease management. BMC
PulmonaryMedicine 2012;12: 11.
21. Tung A, Fergusson NA, Ng N, Hu V, Dormuth C, Griesdale
DEG. Medications to reduce emergence coughing after
general anaesthesia with tracheal intubation: a systematic
review and network meta-analysis. British Journal of
Anaesthesia 2020; 124: 480–495. https://doi.org/10.1016/
j.bja.2019.12.041.
© 2020 The Authors.Anaesthesiapublished by JohnWiley & Sons Ltd on behalf of Association of Anaesthetists 181
Brown et al. | Aerosol generation during intubation and extubation Anaesthesia 2021, 76, 174–181
